MicroPort CardioFlow Medtech Corp. (2160) Stock Statistics & Valuation Metrics

MicroPort CardioFlow Medtech Corp. has a market cap or net worth of HK$1.38B. The enterprise value is HK$336.40M.

MicroPort CardioFlow Medtech Corp. has 1,273,311,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

MicroPort CardioFlow Medtech Corp.’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -2.38%.

The current PE Ratio of MicroPort CardioFlow Medtech Corp. is ―. MicroPort CardioFlow Medtech Corp.’s PEG ratio is -0.11.

In the last 12 months, MicroPort CardioFlow Medtech Corp. had revenue of 443.79M and earned -146.41M in profits. Earnings per share was -0.30.

In the last 12 months, operating cash flow was -25.52M and capital expenditures -518.92M, giving a free cash flow of -544.44M billion.

MicroPort CardioFlow Medtech Corp. pays an annual dividend of ―, resulting in a dividend yield of ―

MicroPort CardioFlow Medtech Corp. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).

MicroPort CardioFlow Medtech Corp. as a current ratio of 2.52, with Debt / Equity ratio of 12.96%

In the past 12 months, MicroPort CardioFlow Medtech Corp. has paid 6.14M in taxes.

MicroPort CardioFlow Medtech Corp. EV to EBITDA ratio is -38.03, with an EV/FCF ratio of -14.25.

MicroPort CardioFlow Medtech Corp. has HK$1.38B in cash and marketable securities with HK$258.36M in debt, giving a net cash position of HK$1.12B billion.

Gross margin is 53.85%, with operating margin of -22.78%, and net profit margin of -32.99%.

The average price target for MicroPort CardioFlow Medtech Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―